- cafead Apr 29, 2020 at 10:42: PM
via Growth has come easily for Tandem Diabetes Care (NASDAQ:TNDM) in recent years. The insulin pump developer grew revenue from $107 million in 2017 to $362 million in 2019. Margins have also improved as the business has scaled. Gross profit soared from $44 million to $194 million in that span, while a full-year 2019 operating loss of $17 million marked a significant improvement from prior years.
article source
article source